Intrommune Therapeutics

Intrommune Therapeutics

Verified
New york-based biotechnology company .

Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$800k—1m (Dealroom.co estimates Jun 2018.)
New York City New York (HQ)
  • Edit
Get premium to view all results
DateInvestorsAmountRound
N/A

$0.0

round
investor

$0.0

round
N/A

$0.0

round
investor investor investor investor

$0.0

round
N/A

N/A

Series B
Total Funding000k

Recent News about Intrommune Therapeutics

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.